AZD7687 Multiple Ascending Dose Study

Study identifier:D2710C00002

ClinicalTrials.gov identifier:N/A

EudraCT identifier:2010-019112-21

CTIS identifier:N/A

Study Complete

Official Title

A Phase 1, Single Centre, Single-Blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AZD7687 after Administration of Multiple Ascending doses in Overweight to Obese but otherwise Healthy Male Subjects

Medical condition

overweight

Phase

Phase 1

Healthy volunteers

Yes

Study drug

AZD7687, Placebo

Sex

All

Actual Enrollment

45

Study type

Interventional

Age

20 Years - 45 Years

Date

Study Start Date: 01 Apr 2010
Primary Completion Date: 01 Mar 2011
Study Completion Date: 01 Mar 2011

Study design

Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Parallel Assignment
Masking: Single Blind
Primary Purpose: Basic Science

Verification:

Verified 01 Dec 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria